Stellar Biotechnologies enters exclusive agreement with Amaran Biotechnology Pharmaceutical Investing
DelMar Pharmaceuticals to Participate in Key Opinion Leader Luncheon on Glioblastoma Multiforme Featuring Dr. James Perry, MD Life Science Investing
NeuroDerm Achieves Primary Endpoint in ND0612H Phase II Trial for Advanced Parkinson’s Disease Pharmaceutical Investing
New Study Shows Potential for Drug Developed to treat Major Depressive Disorder Pharmaceutical Investing
Actinium Pharmaceuticals to obtain patent for key drug ingredient Actinium-225 Pharmaceutical Investing
